Last updated: 2026-09-09 19:42:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
iRhythm Holdings, Inc. (IRTC) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $120.28, with a market capitalization of $4.06B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $100.85 to $212.00. This page covers its latest market performance, valuation, price trends and company information.
$4.06B | |
$122.49 | |
$286.19 | |
$22.16 | |
$122.24 | |
649.51K | |
594.41K | |
-- | |
$212.00 | |
$100.85 | |
-- | |
-- |
iRhythm Holdings, Inc. (IRTC) is currently trading at $120.28 as of 2026-09-09 19:41:00, down 1.61% ($1.96) from the previous close of $122.24
During today's regular trading session, IRTC has traded between $22.16 and $286.19, with a trading volume of 649.51K shares. The current price is near the middle of today's range.
Over the past seven days, iRhythm Holdings, Inc. (IRTC) moved from $120.25 to $120.28, representing a gain of 0.02% ($0.03).
The stock traded between $115.04 and $125.86 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 458.71 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 17.5%
IRTC is currently trading at $120.28, placing it 17.5% of the way from its 52-week low of $100.85 to its 52-week high of $212.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 2400 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of iRhythm Holdings, Inc. (IRTC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.